Announced Fri, 10 Jul · 14:20 IST
RTA certificate filed under SEBI depository regulation 74(5) for Q1 FY27
Compliance View source PDF
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹828.80
prior close
₹833.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—+0.0+0.0—+2.8+2.5+0.9+2.5+1.6+6.3————
Up moveDown movePending
AI summary
Windlas Biotech has submitted to BSE and NSE a certificate from its Registrar and Share Transfer Agent MUFG Intime India, as required under SEBI regulation 74(5) for the quarter ended June 30, 2026. The RTA confirms that no demat requests were received during the quarter and the company holds no physical shares. This is a routine quarterly compliance filing with no business or financial information disclosed.
Likely market impact
Routine regulatory compliance filing with no impact on operations, financials, or shareholder value.